Mindy McCormick, 67, read that her insurer would soon stop covering the weight loss drug Wegovy, which she had been taking for more than two years. Nearly 9,000 people across the state had received ...
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...
The Food and Drug Administration on Friday approved Eli Lilly’s anti-obesity drug Zepbound as the first ... Zepbound, similar ...
US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for ...
Eli Lilly & Co.’s weight-loss shot Zepbound won approval in the US as the first drug to treat sleep apnea, opening the door ...
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Shares of Ozempic-maker Novo Nordisk were down more than 20% in recent trade as the Danish drugmaker headed for its worst day since the 1980s. The stock took a hit after a late-stage trial showed that ...
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.
Signs at AMPAC Fine Chemicals' location in the Petersburg Industrial Park have already been changed to 'Novo Nordisk' in advance of the acquisition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback